A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients

Clinical trial NCT04383067 · UNKNOWN

Trial details

NCT number: NCT04383067
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma

Start date: 2020-05-12
Primary completion: 2022-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.